Yüklüyor......
Recent therapeutic advances in chronic lymphocytic leukemia
The last several years have witnessed a paradigm shift in the management of patients with chronic lymphocytic leukemia (CLL). The course of this very heterogeneous disease, traditionally treated with chemotherapeutic agents usually in combination with rituximab, typically has been characterized by r...
Kaydedildi:
| Yayımlandı: | F1000Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
F1000Research
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5664994/ https://ncbi.nlm.nih.gov/pubmed/29152232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.11618.1 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|